O

Ophthalmic Consultants of the Capital Region | Troy, NY

Research site

(Unclaimed)

Location

2222 Sixth Avenue, Troy, New York, United States of America

Site insights

Top conditions

Top treatments

Zimura

Aflibercept

Prednisolone Acetate

Parent organization

This site is a part of Ophthalmic Consultants of the Capital Region

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) (QUASAR)

Researchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO).In people with RVO, a blood...

Enrolling

Macular Edema Secondary to Retinal Vein Occlusion

Drug: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg

Drug: Sham

Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration

This is a Phase 1, multicenter, open-label, single- and multi-dose, dose-escalating study of OLX10212 in patients with neovascular age-related macula...

Enrolling

Neovascular Age-related Macular Degeneration

Genetic: OLX10212 is a cell penetrating asymmetric small interference RNA (cp-asiRNA)

Trial sponsors

I

O

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms